Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2014

Open Access 01-12-2014 | Research article

Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey

Authors: Anna Girardi, Carlo Piccinni, Emanuel Raschi, Ariola Koci, Benedetta Vitamia, Elisabetta Poluzzi, Fabrizio De Ponti

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Login to get access

Abstract

Background

Use of food supplements-containing phytoestrogens among postmenopausal women is rapidly increasing. Although phytoestrogens are often perceived as safe, evidence for overall positive risk-benefit profile is still inconclusive. The chance to buy them by user’s initiative does not facilitate surveys on their prevalence and pattern of use. The aim of this study was to describe the pattern of use and self-reported positive and negative perceptions of phytoestrogens in post-menopausa.

Methods

A questionnaire was administered to women who were buying food supplements containing phytoestrogens in 22 pharmacies located in the Bologna area (400,000 inhabitants). Questionnaire was structured into 3 sections: (a) socio-demographic information, (b) pattern of use, (c) positive and negative perceptions.

Results

Data on 190 peri- and post-menopausal women (aged 38–77) were collected. Women stated to use phytoestrogens to reduce hot flushes (79%), insomnia (15%), mood disturbances (14%) and prevent osteoporosis (15%). The majority (59%) took phytoestrogens routinely, whereas 28% in 3-month cycles. Among positive perceptions between short- and long-term users, a not negligible difference was reported for relief of hot-flushes (68% in short-term vs. 81% in long-term users; p = 0.04). Negative perceptions were reported more frequently in the long-term group, and this difference was statistically significant for edema (6% in short-term vs. 17% in long-term users; p = 0.04), but not for other effects: e.g., swelling sensation (10% vs. 21%; p = 0.09), somnolence (7% vs. 10% p = 0.62), fatigue (4% vs.11% p = 0.15).

Conclusions

In the Bologna area, the pattern of use of phytoestrogens for menopausal symptoms is heterogeneous, and women overall find these substances to be beneficial, especially for relief of hot-flushes. Other positive perceptions decreased with long-term use. Negative perceptions, especially estrogen-like effects, seem to be infrequent and increase with long-term therapy. Physicians should pay attention to effects perceived by post-menopausal women and routinely monitor the use of phytoestrogens, in order to recognize possible adverse effects and actual benefits.
Appendix
Available only for authorised users
Literature
1.
go back to reference Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De PF: Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem. 2014, 21: 417-436.CrossRefPubMedPubMedCentral Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De PF: Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem. 2014, 21: 417-436.CrossRefPubMedPubMedCentral
2.
go back to reference Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333.CrossRefPubMed Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333.CrossRefPubMed
3.
go back to reference Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013, 310: 1353-1368.CrossRefPubMed Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013, 310: 1353-1368.CrossRefPubMed
4.
go back to reference Majumdar SR, Almasi EA, Stafford RS: Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA. 2004, 292: 1983-1988.CrossRefPubMed Majumdar SR, Almasi EA, Stafford RS: Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA. 2004, 292: 1983-1988.CrossRefPubMed
7.
go back to reference Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J: Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013, 12: CD001395. doi:10.1002/14651858.CD001395.pub4.:CD001395 Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J: Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013, 12: CD001395. doi:10.1002/14651858.CD001395.pub4.:CD001395
8.
go back to reference Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998, 68: 1333S-1346S.PubMed Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998, 68: 1333S-1346S.PubMed
9.
go back to reference Mahady GB, Parrot J, Lee C, Yun GS, Dan A: Botanical dietary supplement use in peri- and postmenopausal women. Menopause. 2003, 10: 65-72.PubMed Mahady GB, Parrot J, Lee C, Yun GS, Dan A: Botanical dietary supplement use in peri- and postmenopausal women. Menopause. 2003, 10: 65-72.PubMed
Metadata
Title
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey
Authors
Anna Girardi
Carlo Piccinni
Emanuel Raschi
Ariola Koci
Benedetta Vitamia
Elisabetta Poluzzi
Fabrizio De Ponti
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-14-262

Other articles of this Issue 1/2014

BMC Complementary Medicine and Therapies 1/2014 Go to the issue